Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous phenylephrine versus ondansetron for prevention of hypotension during elective caesarean section
PACTR202301602396344Phase 0Not yet recruiting
- Sponsor
- Mansoura University
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0 trial of phenylephrine and ondansetron (2 arms), sponsored by Mansoura University. Primary endpoint: Mean arterial blood pressure. Planned start Dec 2022; status: not yet recruiting.
02
Drugs
phenylephrineondansetron
Beyond the preview
Go deeper on PACTR202301602396344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202301602396344.